Hannestad, U.; Allard, A.; Nilsson, K.; Rosén, A.
Prevalence of EBV, HHV6, HCMV, HAdV, SARS-CoV-2, and Autoantibodies to Type I Interferon in Sputum from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Viruses 2025, 17, 422.
https://doi.org/10.3390/v17030422
AMA Style
Hannestad U, Allard A, Nilsson K, Rosén A.
Prevalence of EBV, HHV6, HCMV, HAdV, SARS-CoV-2, and Autoantibodies to Type I Interferon in Sputum from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Viruses. 2025; 17(3):422.
https://doi.org/10.3390/v17030422
Chicago/Turabian Style
Hannestad, Ulf, Annika Allard, Kent Nilsson, and Anders Rosén.
2025. "Prevalence of EBV, HHV6, HCMV, HAdV, SARS-CoV-2, and Autoantibodies to Type I Interferon in Sputum from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients" Viruses 17, no. 3: 422.
https://doi.org/10.3390/v17030422
APA Style
Hannestad, U., Allard, A., Nilsson, K., & Rosén, A.
(2025). Prevalence of EBV, HHV6, HCMV, HAdV, SARS-CoV-2, and Autoantibodies to Type I Interferon in Sputum from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Viruses, 17(3), 422.
https://doi.org/10.3390/v17030422